Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma
NCT04076761
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class
Stopped
Lack of Funding
Conditions
Cholangiocarcinoma
Bile Duct Cancer
Interventions
DRUG:
Trifluridine/Tipiracil
Sponsor
Sunnybrook Health Sciences Centre
Collaborators
[object Object]